Literature DB >> 20465986

Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides.

Marjan Javanbakht1, Ryan Murphy, Pamina Gorbach, Marc-André LeBlanc, Jim Pickett.   

Abstract

BACKGROUND: The importance of the acceptability of rectal microbicides for HIV and sexually transmissible infections (STIs) prevention is widely recognised. Given relatively consistent use of lubricants for anal intercourse (AI) and the potential for lubricant-like rectal microbicides, understanding barriers to lubricant use may help inform hurdles likely to be encountered once a rectal microbicide becomes available.
METHODS: We conducted an internet-based survey using a 25-item questionnaire to assess AI and lubricant use, including lubricant preferences and barriers to use.
RESULTS: The majority of the 6124 respondents who reported AI were male (93%), 25 years or older (80%) and from North America (70%). Consistent condom use during AI was reported by a minority (35%) and consistent lubricant use was reported by over half of respondents. Reasons for non-use differed by age and region. Among men, those <25 years were more likely to report barriers around cost compared with those 45 and older (odds ratio (OR) = 6.64; 95% confidence interval (CI) 3.14-14.03). European men (OR = 1.92; 95% CI 1.50-2.45), Latin American women (OR = 3.69; 95% CI 1.27-10.75) and Asian women (OR = 4.04; 95% CI 1.39-11.78) were more likely to report sexual preference as a reason for non-use.
CONCLUSIONS: Rectal lubricants are widely used, but barriers to use vary by age and region for dry sex. A lubricant-like rectal microbicide would potentially be acceptable and such a product may be useful as a method of HIV prevention. However, targeted marketing and educational approaches may be needed to enhance use and acceptability of such a product.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465986     DOI: 10.1071/SH09062

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  16 in total

1.  Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; José Bauermeister; Cheng-Shiun Leu; Juan Valladares; Lisa C Rohan; Peter A Anton; Ross D Cranston; Irma Febo; Kenneth Mayer; Ian McGowan
Journal:  AIDS Behav       Date:  2014-09

2.  Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.

Authors:  Heather A Pines; Pamina M Gorbach; Cathy J Reback; Raphael J Landovitz; Matt G Mutchler; Ronald Mitsuyasu
Journal:  AIDS Care       Date:  2014-07-15

3.  Attitudes and perceptions of biomedical HIV prevention methods: voices from young men who have sex with men.

Authors:  Katrina Kubicek; Cesar Arauz-Cuadra; Michele D Kipke
Journal:  Arch Sex Behav       Date:  2015-01-30

4.  Preparing for rectal microbicides: sociocultural factors affecting product uptake among potential South American users.

Authors:  Jerome T Galea; Janni J Kinsler; John Imrie; César R Nureña; Lucía Ruiz; Luis Fernando Galarza; Jorge Sánchez; William E Cunningham
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

5.  The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk.

Authors:  Pamina M Gorbach; Robert E Weiss; Edward Fuchs; Robin A Jeffries; Marjan Hezerah; Stephen Brown; Alen Voskanian; Edward Robbie; Peter Anton; Ross D Cranston
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

6.  Does Stigma Toward Anal Sexuality Impede HIV Prevention Among Men Who Have Sex With Men in the United States? A Structural Equation Modeling Assessment.

Authors:  Bryan A Kutner; Jane M Simoni; Kevin M King; Steven M Goodreau; Andrea Norcini Pala; Emma Creegan; Frances M Aunon; Stefan D Baral; B R Simon Rosser
Journal:  J Sex Med       Date:  2020-01-10       Impact factor: 3.802

Review 7.  Rectal microbicide development.

Authors:  Ian McGowan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 8.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

10.  Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.

Authors:  Timothy Frasca; Rebecca Giguere; Mobolaji Ibitoye; Curtis Dolezal; Irma Febo; Ross D Cranston; Kenneth Mayer; Ian McGowan; Alex Carballo-Diéguez
Journal:  Arch Sex Behav       Date:  2016-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.